Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13983* | 2021 |
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level IB Sahra, K Laurent, A Loubat, S Giorgetti-Peraldi, P Colosetti, P Auberger, ... Oncogene 27 (25), 3576-3586, 2008 | 1108 | 2008 |
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1 I Ben Sahra, C Regazzetti, G Robert, K Laurent, Y Le Marchand-Brustel, ... Cancer research 71 (13), 4366-4372, 2011 | 727 | 2011 |
The role of MAPKs in adipocyte differentiation and obesity F Bost, M Aouadi, L Caron, B Binétruy Biochimie 87 (1), 51-56, 2005 | 661 | 2005 |
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells I Ben Sahra, K Laurent, S Giuliano, F Larbret, G Ponzio, P Gounon, ... Cancer research 70 (6), 2465-2475, 2010 | 643 | 2010 |
Metformin in cancer therapy: a new perspective for an old antidiabetic drug? I Ben Sahra, Y Le Marchand-Brustel, JF Tanti, F Bost Molecular cancer therapeutics 9 (5), 1092-1099, 2010 | 636 | 2010 |
Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells YY Wang, C Attané, D Milhas, B Dirat, S Dauvillier, A Guerard, J Gilhodes, ... JCI insight 2 (4), e87489, 2017 | 432 | 2017 |
The extracellular signal–regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis F Bost, M Aouadi, L Caron, P Even, N Belmonte, M Prot, C Dani, ... Diabetes 54 (2), 402-411, 2005 | 420 | 2005 |
Hypoxia decreases insulin signaling pathways in adipocytes C Regazzetti, P Peraldi, T Grémeaux, R Najem-Lendom, I Ben-Sahra, ... Diabetes 58 (1), 95-103, 2009 | 345 | 2009 |
The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin O Potapova, A Haghighi, F Bost, C Liu, MJ Birrer, R Gjerset, D Mercola Journal of Biological Chemistry 272 (22), 14041-14044, 1997 | 290 | 1997 |
Inter‐α‐trypsin inhibitor proteoglycan family: A group of proteins binding and stabilizing the extracellular matrix F Bost, M Diarra‐Mehrpour, JP Martin European Journal of Biochemistry 252 (3), 339-346, 1998 | 262 | 1998 |
Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage F Bost, L Caron, I Marchetti, C Dani, YLE MARCHAND-BRUSTEL, ... Biochemical Journal 361 (3), 621-627, 2002 | 252 | 2002 |
Role of MAPKs in development and differentiation: lessons from knockout mice M Aouadi, B Binetruy, L Caron, Y Le Marchand-Brustel, F Bost Biochimie 88 (9), 1091-1098, 2006 | 226 | 2006 |
Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans C Dray, C Debard, J Jager, E Disse, D Daviaud, P Martin, C Attané, ... American journal of physiology-endocrinology and metabolism 298 (6), E1161-E1169, 2010 | 222 | 2010 |
Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines Y Li, B Lin, A Agadir, R Liu, MI Dawson, JC Reed, JA Fontana, F Bost, ... Molecular and cellular biology 18 (8), 4719-4731, 1998 | 220 | 1998 |
Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages M Aouadi, K Laurent, M Prot, Y Le Marchand-Brustel, B Binétruy, F Bost Diabetes 55 (2), 281-289, 2006 | 217 | 2006 |
The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells F Bost, R McKay, N Dean, D Mercola Journal of Biological Chemistry 272 (52), 33422-33429, 1997 | 198 | 1997 |
The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells F Bost, R McKay, M Bost, O Potapova, NM Dean, D Mercola Molecular and cellular biology 19 (3), 1938-1949, 1999 | 191 | 1999 |
The metabolic modulator PGC-1α in cancer F Bost, L Kaminski American journal of cancer research 9 (2), 198, 2019 | 179 | 2019 |
Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death I Ben-Sahra, B Dirat, K Laurent, A Puissant, P Auberger, A Budanov, ... Cell Death & Differentiation 20 (4), 611-619, 2013 | 168 | 2013 |